Your shopping cart is empty!
Menveo Vaccine (A, C, W135, Y Conj.) Powder & Solution for Injection
Menveo Vaccine.
Meningococcal Group A, C, W135 and Y Conjugate Vaccine.
Indications:
Menveo is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. Menveo is approved for use in persons 2 to 55 years of age. Menveo does not prevent N. meningitidis serogroup B infections.
Manufacturer:
Novartis Vaccines
£35.75